2.High-dose methotrexate plus hematopoietic stem cell transplantation supplemented by rituximab intrathecal injection for primary central nervous system lymphoma:two cases report and literature review.
Jin-hong JIANG ; Bing-mu FANG ; Ye-hui XU
Chinese Journal of Hematology 2013;34(2):162-163
Adult
;
Antibodies, Monoclonal, Murine-Derived
;
therapeutic use
;
Central Nervous System Neoplasms
;
therapy
;
Female
;
Hematopoietic Stem Cell Transplantation
;
Humans
;
Injections, Spinal
;
Lymphoma, Non-Hodgkin
;
therapy
;
Male
;
Methotrexate
;
administration & dosage
;
therapeutic use
;
Middle Aged
;
Rituximab
3.Detection of serum CEA mRNA and CEA proteins in patients with breast cancer and its clinical significance.
Tao JIN ; Da-Fang CHEN ; Lin-Hui GU
Chinese Journal of Oncology 2007;29(3):214-215
Adult
;
Aged
;
Breast Neoplasms
;
blood
;
pathology
;
Carcinoembryonic Antigen
;
blood
;
genetics
;
Carcinoma, Ductal, Breast
;
blood
;
secondary
;
Female
;
Fibroadenoma
;
blood
;
Fibrocystic Breast Disease
;
blood
;
Humans
;
Lymphatic Metastasis
;
Middle Aged
;
Neoplasm Staging
;
RNA, Messenger
;
blood
;
genetics
4.Analysis of phenotype and genotype in a Chinese pedigree with inherited prothrombin deficiency resulted from a homozygous mutation Tyr510Asp.
Yan-hui JIN ; Ming-shan WANG ; Fang-xiu ZHENG
Chinese Journal of Hematology 2012;33(7):587-589
Adolescent
;
Adult
;
Amino Acid Sequence
;
Genotype
;
Homozygote
;
Humans
;
Hypoprothrombinemias
;
etiology
;
genetics
;
Male
;
Middle Aged
;
Molecular Sequence Data
;
Mutation
;
Pedigree
;
Phenotype
;
Young Adult
5.Change of peripheral blood appetite regulation factor of anorexia children and infect of child anorexia granule.
Ai-Hua HU ; Hui-Min XU ; Guo-Hua HU ; Fang JIN ; Zhong LI ; Guo-Xing FANG
China Journal of Chinese Materia Medica 2014;39(23):4685-4688
Study the infect of child anorexia granule on serum ghrelin and leptin of anorexia children and its clinical efficacy. Selected 81 cases of anorexia children aged 1-6 years old into treatment group (42 cases) and control group (39 cases), in addition, 30 case healthy children as healthy control group. The control group children were treated with domperidone suspension 0.3 mg x kg(-1) x d(-1), tid, orally 30 minutes before meals. Treatment group were treated with child anorexia granule, 1-3 years 1 package, bid; 4-6 years 1 package, tid; po, 4 weeks as a course of treatment. Study the change of serum ghrelin and leptin before and after therapy. The study demonstrates that before treatment, the serum ghrelin level of disease group was lower than healthy group (P < 0.01), and the serum leptin level was higher than healthy group (P < 0.01). After treatment, the serum ghrelin level both increase, and the serum leptin decline. And the change of treatment group was significantly different with control group (P < 0.01). And the clinical effective rate are 95.23% and 74.35% (P < 0.01). After 6 months of follow-up visit, the children weight significantly increase in treatment group (P < 0.01). Results indicate that child anorexia granule can facilitate secretion of ghrelin, and inhibit secretion of leptin, so as to work up an appetite. And the molecular mechanism is its infect on serum ghrelin, leptin.
Anorexia
;
drug therapy
;
metabolism
;
physiopathology
;
Appetite Regulation
;
drug effects
;
Body Weight
;
drug effects
;
Child
;
Child, Preschool
;
Drugs, Chinese Herbal
;
administration & dosage
;
Female
;
Ghrelin
;
metabolism
;
Humans
;
Infant
;
Leptin
;
metabolism
;
Male
6.Enhance the Expression of B. subtillis Fibrinolysis Enzyme by degQ Gene
Ming-Fei JIN ; Xin-Hua ZHU ; Li JIN ; Hui-Fang BIAN ; Zi-Rong WU ;
Microbiology 1992;0(02):-
The degQ gene, amplified from Bacillus subtilis by PCR, was cloned to pUBS (sucrose induced secretion vector). After transformed into DB403, recombination named DB403(pUBSD) was formed. The results of the fermentation showed that degQ gene enhanced the expression of B. subtilis fibrin enzyme. The activity of the enzyme was increased to 2.2 times as the original one. In this article, the effects of different conditions, such as different kinds of sugar, different concentration of sucrose and different induced time were also be investigated and compared.
7.Postmastectomy hypofractionation radiotherapy in high-risk breast cancer patients: A phase Ⅰ/Ⅱ clinical trial
Shulian WANG ; Yexiong LI ; Yongwen SONG ; Jing JIN ; Hui FANG ; Yuan QU ; Zhouguang HUI ; Weihu WANG ; Zihao YU ; Xinfan LIU
Chinese Journal of Radiation Oncology 2009;18(3):197-199
Objective To investigate the efficacy and toxicity of postmastectomy hypofractionation radiotherapy in patients with high-risk breast cancer. Methods Postmastectomy radiation of 43.5 Gy in 15 fractions of 2.9 Gy over 3 weeks was delivered to 38 patients with breast cancer. The incidence of acute radi-ation toxicity and lecoregional recurrence was evaluated. Results With a median follow up of 13 months, all patients were alive. No patient had locoregional recurrence within radiation field. Five (13%) had dis-tant metastases. Five (13%) developed grade 3 radiation dermatitis at 2 to 3 weeks after the course of radia-tion. Three (8%) had grade 2 radiation pneumonitis. Conclusions Hypofractionation radiation of 43.5 Gy in 15 fractions of 2.9 Gy over 3 weeks is effective in the near time for patients with high-risk breast cancer after mastectomy, and the acute toxicities are tolerable.
8.The molecular mechanism of interaction of trivalent dimethylarsinous acid (DMA(III)) binding to rat hemoglobin.
Min ZHANG ; Wen-Wen WANG ; Hui-Fang JIN ; Ling-Ling BAO ; Hua NARANMANDURA ; Ying-Jie QIN ; Chun-Hui LI
Acta Pharmaceutica Sinica 2014;49(5):666-671
In our previous work, we found that trivalent dimethylarsinous acid (DMA(III)) have high affinity binding to cysteine residue 13 of rat hemoglobin. However, it is still unknown why arsenic intermediate metabolite DMA(III) has high binding affinity for Cysl3 but not for other cysteine residues 93, 140, 111 and 125. In order to better understand the molecular mechanism of DMA(III) with rat hemoglobin, we have done current study. So, SD rats were divided into control and arsenic-treated groups randomly. Arsenic species in lysate of red blood cells were analyzed by HPLC-ICP-MS, and then determined by a hybrid quadrupole TOF MS. In addition, trivalent DMA(III) binds to different cysteine residues in rat hemoglobin alpha and beta chains were also simulated by Molecular Docking. Only Cys13 in alpha chain is able to bind to DMA(III) from the experiment results. Cys13 of alpha chain in rat hemoglobin is a specific binding site for DMA(III), and we found that amino acids compose pockets structure and surround Cys13 (but not other cysteine residues), make DMA(III) much easy to bind cysteine 13. Taken together, the DMA(III) specific binding to Cys13 is related to spatial structure of Cys13.
Animals
;
Arsenic
;
metabolism
;
Binding Sites
;
Cacodylic Acid
;
analogs & derivatives
;
chemistry
;
Chromatography, High Pressure Liquid
;
Cysteine
;
metabolism
;
Hemoglobins
;
metabolism
;
Mass Spectrometry
;
Peptide Fragments
;
metabolism
;
Rats
9.The prognostic value of HIF-1α and VEGF expression in hypopharyngeal squamous cell carcinoma
Ting JIN ; Fang WANG ; Weihan HU ; Nan GE ; Tao XU ; Hui LIN
Chinese Journal of Radiation Oncology 2011;20(5):385-389
ObjectiveTo examine the relationship between HIF-1αt and VEGF expression and the clinicopathological characteristics in hypopharyngeal squamous cell carcinoma. Methods The expression status of HIF-1α and VEGF were examined by immunohistochemistric method (IHC) in 62 tumor tissue and 19 paracancerous normal tissue.The relationships between the expression of HIF-1α and VEGF and clinicopathological characteristic were analyzed. Results HIF-1αt and VEGF expression were higher in hypopharyngeal carcinoma tissues than those in paracancerous normal tissues (66. 1%:26. 3% ;x2 =18. 02,P <0. 05 ;67. 7% : 31.6% ; x2 =19.22, P < 0. 05 ). The expression intensity of HIF-1 α was related to T stage, N stage and TNM stage ( x2 =4. 23,5.83,9.94,all P <0. 05). The expression intensity of VEGF was related to metastasis, T stage, N stage and TNM stage (x2 =5.62,7. 38,15.75,4. 29 ,all P <0. 05 ). There was minus relationship between overall survival and expression level of HIF-1 α and/or VEGF (x2 =29. 25, P<0.01; x2 =24.88, P< 0.01 ).On multivariate analysis,HIF-1α expression and T stage were independent prognostic factors for overall survival (x2 =4.80,5.74, all P<0. 05).ConclusionsHIF-1α and VEGF may be considered as a parameter in evaluation of progression, metastasis and prognosis of hypopharyngeal carcinoma and also may be a direction of molecular target therapy.
10.Research about formulas for activating blood and resolving stasis Xuesaitong capsule regulate CD117+ hemopoietic stem cell to produce new blood.
Bao-Xia ZHANG ; Jin-Sheng ZHANG ; Mei-Mei DU ; Yang-Yang ZHANG ; Hui-Fang ZHU
China Journal of Chinese Materia Medica 2014;39(12):2341-2344
OBJECTIVETo investigate the mechanism that the formulas for activating blood and resolving stasis can regulate hemopoietic stem cell to produce new blood.
METHODRats were established animal model of acute cerebral infarction by referencing Olivette' method. They were randomly divided into model group, the group of the high, middle, low dose of the formulas for activating blood and resolving stasis. Each group and then wasrandomly divided into subgroups by 1, 3, 7, 14, 28 d. Xuesaitong capsule was formulated into 20, 40, 60 g x L(-1) with normal saline. The rats were given gavage drugs once a day until the experient ended, and the model group was administrated by intragastrical perfusion of normal saline. ELISA was used to detect the expression of SCF in peripheral blood and bone marrow among different groups at different time points. Flow cytometry was used to observe the changes of CD117 in blood and bone marrow.
RESULTThe CD117+ HSC and SCF concentration in peripheral blood and bone marrow of model group were increasing during 1-14 d,there was a peak on the 14th day, then the expression was reducing. CD117+ HSC and SCF concentration rising trend in the group of the high, middle dose of the formulas for activating blood and resolving stasis was preceded model group (P < 0.05).
CONCLUSIONActivating blood and resolving stasis can regulate hemopoietic stem cell to produce new blood, and it is through the regulation of CD117+ HSC number to achieve the purpose.
Animals ; Bone Marrow Cells ; drug effects ; metabolism ; Capsules ; Cerebral Infarction ; blood ; drug therapy ; genetics ; metabolism ; Chemistry, Pharmaceutical ; Drugs, Chinese Herbal ; administration & dosage ; Hematopoietic Stem Cells ; drug effects ; metabolism ; Humans ; Male ; Proto-Oncogene Proteins c-kit ; genetics ; metabolism ; Rats ; Rats, Sprague-Dawley ; Stem Cell Factor ; genetics ; metabolism